What is Elevation Oncology, Inc. (ELEV)?
Elevation Oncology, Inc. (ELEV) is a stock traded on the Cboe One exchange, quoted in USD. It's a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer. As with any single equity, its price action reflects company-specific catalysts such as clinical trial results and broader biotech sentiment. On TradeSearcher, ELEV is supported by over 1,500 backtests spanning data that reaches back to 2015, giving traders a deep, multi-year foundation to evaluate how different strategies have performed across a wide range of market conditions.